Open | - |
Close | - |
Volume / Avg. | 0 / 116.465K |
Day Range | - - - |
52 Wk Range | 4.235 - 11.645 |
Market Cap | $129.791M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | % |
Days to Cover | 6.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TELA Bio (NASDAQ: TELA) through any online brokerage.
Other companies in TELA Bio’s space includes: RxSight (NASDAQ:RXST), Meihua Intl Medical Techs (NASDAQ:MHUA), Embecta (NASDAQ:EMBC), NexGel (NASDAQ:NXGL) and Align Tech (NASDAQ:ALGN).
The latest price target for TELA Bio (NASDAQ: TELA) was reported by Lake Street on Wednesday, December 27, 2023. The analyst firm set a price target for 14.00 expecting TELA to rise to within 12 months (a possible 164.15% upside). 4 analyst firms have reported ratings in the last year.
The stock price for TELA Bio (NASDAQ: TELA) is $5.3 last updated March 18, 2024 at 4:01 PM EDT.
There are no upcoming dividends for TELA Bio.
TELA Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for TELA Bio.
TELA Bio is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.